Tonelli Marcello, Wang Wenjie, Hemmelgarn Brenda, Lloyd Anita, Manns Braden
Department of Medicine, University of Alberta, Edmonton, Canada.
Am J Kidney Dis. 2009 Dec;54(6):1108-15. doi: 10.1053/j.ajkd.2009.05.018. Epub 2009 Jul 19.
Currently available phosphate binders are associated with either hypercalcemia or high costs, which limit their use in hemodialysis patients. Whether modifying dialysis prescription to intensify small-solute clearance also leads to better phosphate clearance is unknown.
Randomized crossover trial.
Large patients (>80 kg; N = 18) who could not achieve adequate Kt/V during a standard 4-hour thrice-weekly prescription of maintenance hemodialysis.
2 high-flux dialyzers in parallel for 4 hours in comparison to 3 other dialysis modalities (4 hours of standard hemodialysis, 4.5 hours of hemodialysis, and 4 hours of hemodialysis with increased dialysate flow).
(1) Predialysis serum phosphate level, (2) postdialysis phosphate level, (3) phosphate clearance, and (4) phosphate removal, all assessed during the last midweek session for each of the 4 different modalities.
Mean baseline predialysis serum phosphate level was 5.95 +/- 1.95 mg/dL. Using 2 dialyzers in parallel was associated with a significant decrease in predialysis serum phosphate level compared with standard hemodialysis (1.33 mg/dL lower; P = 0.01). Mean serum postdialysis serum phosphate levels during the last treatment of the double-dialyzer period were also lower by 0.43 and 0.74 mg/dL than during the last treatment of the standard-hemodialysis (P = 0.05) and increased-dialysate-flow (P < 0.001) periods, respectively. The double-dialyzer strategy also was associated with greater phosphate clearance (177.2 [corrected] mL/min; 95% confidence interval [CI], 158.6 to 195.9) [corrected] than the other 3 strategies (129.8 [corrected] mL/min; 95% CI, 111.2 to 148.4; 135.4 mL/min; 95% CI, 115.4 to 155.3; and 131.2 mL/min; 95% CI, 112.0 to 150.4), [corrected] but not greater phosphate removal.
Small sample size, short study duration, and results of phosphate removal analysis inconclusive.
Use of 2 dialyzers in parallel for 6 weeks in overweight hemodialysis patients led to substantially lower predialysis phosphate levels. Future studies should explore the potential contribution of increased dialyzer surface area to better control of serum phosphate levels in maintenance hemodialysis patients.
目前可用的磷结合剂与高钙血症或高成本相关,这限制了它们在血液透析患者中的应用。改变透析处方以加强小分子溶质清除是否也能带来更好的磷清除尚不清楚。
随机交叉试验。
体重较大(>80 kg;N = 18)的患者,他们在每周三次、每次4小时的标准维持性血液透析处方期间无法达到足够的Kt/V。
与其他3种透析方式(4小时标准血液透析、4.5小时血液透析、4小时增加透析液流量的血液透析)相比,并行使用2个高通量透析器4小时。
(1)透析前血清磷水平,(2)透析后磷水平,(3)磷清除率,(4)磷清除量,均在4种不同方式的最后一次周中治疗期间进行评估。
平均基线透析前血清磷水平为5.95±1.95mg/dL。与标准血液透析相比,并行使用2个透析器与透析前血清磷水平显著降低相关(低1.33mg/dL;P = 0.01)。在双透析器治疗期的最后一次治疗期间,透析后血清磷平均水平分别比标准血液透析(P = 0.05)和增加透析液流量(P < 0.001)治疗期的最后一次治疗低0.43和0.74mg/dL。双透析器策略也与更高的磷清除率(177.2[校正后]mL/min;95%置信区间[CI],158.6至195.9)[校正后]相关,高于其他3种策略(129.8[校正后]mL/min;95%CI,111.2至148.4;135.4mL/min;95%CI,115.4至155.3;以及131.2mL/min;95%CI,112.0至150.4)[校正后],但磷清除量并不更高。
样本量小、研究持续时间短,且磷清除量分析结果无定论。
超重血液透析患者并行使用2个透析器6周可使透析前磷水平大幅降低。未来研究应探索增加透析器表面积对更好控制维持性血液透析患者血清磷水平的潜在作用。